Vasoconstricting agonists elevate the intracellular Ca2+ concentration
and induce tension development in vascular smooth muscle cells by ind
ucing both Ca2+ influx from the extracellular space and Ca2+ release f
rom cellular stores. The relative importance of Ca2+ release has been
found to vary between different sites in the vasculature. This review
examines the role of Ca2+ release in the activation of cerebral arteri
es produced by several vasoconstricting stimuli. Although the activati
on of cerebral arteries by agonists such as 5-hydroxytryptamine and no
radrenaline has typically been found to have little dependence on Ca2 release, other vasoconstrictors such as thromboxane A(2), which may b
e released from the endothelium by other agonists, appear to induce a
substantial intracellular Ca2+ release in cerebral arteries. The limit
ed efficacy of Ca2+ influx blockers in the treatment of delayed cerebr
ovascular constriction occurring as a result of subarachnoid haemorrha
ge suggests that intracellular mechanisms such as Ca2+ release and/or
the activation of protein kinase C may be important determinants of va
soconstriction under pathological conditions.